BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT04895696 updates: 1. primary completion date: 2026-06-18 → 2026-06-12 2. enrollment: 268 → 248 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04895696 updates: 1. primary completion date: 2026-06-18 → 2026-06-12 2. enrollment: 268 → 248 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical